Curis | CRIS - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Bayer EUR 31.83B 877M 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
CSL USD 10.42B 273M 2025-12
Curis USD 29.43M 10.69M 2024-06
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Incyte USD 30.2M 5.17M 2025-12
Merck USD 39.97B 6B 2025-09
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Takeda JPY 4.27T 81.29B 2025-12
TG Therapeutics USD 245.64M 305K 2025-12
Verastem USD 81.33M 31.01M 2025-12
Xoma USD 94.38M 7.82M 2025-09